These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 20149325)

  • 1. Risk and management of liver toxicity during methotrexate treatment in rheumatoid and psoriatic arthritis: a systematic review of the literature.
    Visser K; van der Heijde DM
    Clin Exp Rheumatol; 2009; 27(6):1017-25. PubMed ID: 20149325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated liver enzyme tests among patients with rheumatoid arthritis or psoriatic arthritis treated with methotrexate and/or leflunomide.
    Curtis JR; Beukelman T; Onofrei A; Cassell S; Greenberg JD; Kavanaugh A; Reed G; Strand V; Kremer JM
    Ann Rheum Dis; 2010 Jan; 69(1):43-7. PubMed ID: 19147616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. "Hepatic toxicity by methotrexate with weekly single doses associated with folic acid in rheumatoid and psoriatic arthritis. What is its real frequency?".
    García DS; Saturansky EI; Poncino D; Martínez-Artola Y; Rosenberg S; Abritta G; Ascimani-Peña C; Cravero A
    Ann Hepatol; 2019; 18(5):765-769. PubMed ID: 31105018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methotrexate-induced pneumonitis in patients with rheumatoid arthritis and psoriatic arthritis: report of five cases and review of the literature.
    Salaffi F; Manganelli P; Carotti M; Subiaco S; Lamanna G; Cervini C
    Clin Rheumatol; 1997 May; 16(3):296-304. PubMed ID: 9184269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methotrexate in psoriasis: a systematic review of treatment modalities, incidence, risk factors and monitoring of liver toxicity.
    Montaudié H; Sbidian E; Paul C; Maza A; Gallini A; Aractingi S; Aubin F; Bachelez H; Cribier B; Joly P; Jullien D; Le Maître M; Misery L; Richard MA; Ortonne JP
    J Eur Acad Dermatol Venereol; 2011 May; 25 Suppl 2():12-8. PubMed ID: 21388454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver fibrosis in patients with psoriasis and psoriatic arthritis on long-term, high cumulative dose methotrexate therapy.
    Lindsay K; Fraser AD; Layton A; Goodfield M; Gruss H; Gough A
    Rheumatology (Oxford); 2009 May; 48(5):569-72. PubMed ID: 19273538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Golimumab: Review of the efficacy and tolerability of a recently approved tumor necrosis factor-α inhibitor.
    Boyce EG; Halilovic J; Stan-Ugbene O
    Clin Ther; 2010 Sep; 32(10):1681-703. PubMed ID: 21194591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness and retention rates of methotrexate in psoriatic arthritis in comparison with methotrexate-treated patients with rheumatoid arthritis.
    Lie E; van der Heijde D; Uhlig T; Heiberg MS; Koldingsnes W; Rødevand E; Kaufmann C; Mikkelsen K; Kvien TK
    Ann Rheum Dis; 2010 Apr; 69(4):671-6. PubMed ID: 19740904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term safety of methotrexate monotherapy in patients with rheumatoid arthritis: a systematic literature research.
    Salliot C; van der Heijde D
    Ann Rheum Dis; 2009 Jul; 68(7):1100-4. PubMed ID: 19060002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rare incidence of methotrexate-specific lesions in liver biopsy of patients with arthritis and elevated liver enzymes.
    Quintin E; Scoazec JY; Marotte H; Miossec P
    Arthritis Res Ther; 2010; 12(4):R143. PubMed ID: 20637063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of liver disease in patients with psoriasis, psoriatic arthritis, and rheumatoid arthritis receiving methotrexate: A population-based study.
    Gelfand JM; Wan J; Zhang H; Shin DB; Ogdie A; Syed MN; Egeberg A
    J Am Acad Dermatol; 2021 Jun; 84(6):1636-1643. PubMed ID: 33607181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methotrexate treatment in rheumatoid arthritis and elevated liver enzymes: A long-term follow-up of predictors, surveillance, and outcome in clinical practice.
    Karlsson Sundbaum J; Eriksson N; Hallberg P; Lehto N; Wadelius M; Baecklund E
    Int J Rheum Dis; 2019 Jul; 22(7):1226-1232. PubMed ID: 31012257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Methotrexate, liver and rheumatoid arthritis in tropical areas].
    Diouf ML; Diallo S; Mbengue M; Moreira-Diop T
    Sante; 2001; 11(3):195-200. PubMed ID: 11641084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Usefulness of the American College of Rheumatology recommendations for liver biopsy in methotrexate-treated rheumatoid arthritis patients.
    Erickson AR; Reddy V; Vogelgesang SA; West SG
    Arthritis Rheum; 1995 Aug; 38(8):1115-9. PubMed ID: 7639808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatoprotective effect of tumour necrosis factor alpha blockade in psoriatic arthritis: a cross-sectional study.
    Seitz M; Reichenbach S; Möller B; Zwahlen M; Villiger PM; Dufour JF
    Ann Rheum Dis; 2010 Jun; 69(6):1148-50. PubMed ID: 19854710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver toxicity is rare in rheumatoid arthritis patients using combination therapy with leflunomide and methotrexate.
    Alves JA; Fialho SC; Morato EF; Castro GR; Zimmermann AF; Ribeiro GG; Neves FS; Pereira IA
    Rev Bras Reumatol; 2011; 51(2):141-4. PubMed ID: 21584420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatotoxicity rates do not differ in patients with rheumatoid arthritis and psoriasis treated with methotrexate.
    Amital H; Arnson Y; Chodick G; Shalev V
    Rheumatology (Oxford); 2009 Sep; 48(9):1107-10. PubMed ID: 19578136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Limitations of clinical trials in chronic diseases: is the efficacy of methotrexate (MTX) underestimated in polyarticular psoriatic arthritis on the basis of limitations of clinical trials more than on limitations of MTX, as was seen in rheumatoid arthritis?
    Pincus T; Bergman MJ; Yazici Y
    Clin Exp Rheumatol; 2015; 33(5 Suppl 93):S82-93. PubMed ID: 26472658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical liver disease in patients with rheumatoid arthritis taking methotrexate.
    Phillips CA; Cera PJ; Mangan TF; Newman ED
    J Rheumatol; 1992 Feb; 19(2):229-33. PubMed ID: 1629819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Indispensable or intolerable? Methotrexate in patients with rheumatoid and psoriatic arthritis: a retrospective review of discontinuation rates from a large UK cohort.
    Nikiphorou E; Negoescu A; Fitzpatrick JD; Goudie CT; Badcock A; Östör AJ; Malaviya AP
    Clin Rheumatol; 2014 May; 33(5):609-14. PubMed ID: 24609758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.